A cost analysis of 115 robotic-assisted laparoscopic radical prostatectomies (RARPs) and 358 open radical retropubic prostatectomies (RRPs) demonstrated that the overall cost per case for RARP exceeded the cost for RRP by almost $5,300, mainly due to higher operating room supply costs (nearly seven times greater for RARP) and indirect costs associated with the purchase and maintenance of the robotic equipment.
Led by Joel B. Nelson, MD, the team reported in Urology no significant difference in mean length of stay for RARP patients (1.2 days) compared with RRP patients (1.4 days).
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.